Literature DB >> 33497675

Predictive Analytics for Glaucoma Using Data From the All of Us Research Program.

Sally L Baxter1, Bharanidharan Radha Saseendrakumar2, Paulina Paul3, Jihoon Kim3, Luca Bonomi3, Tsung-Ting Kuo3, Roxana Loperena4, Francis Ratsimbazafy4, Eric Boerwinkle5, Mine Cicek6, Cheryl R Clark7, Elizabeth Cohn8, Kelly Gebo9, Kelsey Mayo4, Stephen Mockrin10, Sheri D Schully11, Andrea Ramirez12, Lucila Ohno-Machado13.   

Abstract

PURPOSE: To (1) use All of Us (AoU) data to validate a previously published single-center model predicting the need for surgery among individuals with glaucoma, (2) train new models using AoU data, and (3) share insights regarding this novel data source for ophthalmic research.
DESIGN: Development and evaluation of machine learning models.
METHODS: Electronic health record data were extracted from AoU for 1,231 adults diagnosed with primary open-angle glaucoma. The single-center model was applied to AoU data for external validation. AoU data were then used to train new models for predicting the need for glaucoma surgery using multivariable logistic regression, artificial neural networks, and random forests. Five-fold cross-validation was performed. Model performance was evaluated based on area under the receiver operating characteristic curve (AUC), accuracy, precision, and recall.
RESULTS: The mean (standard deviation) age of the AoU cohort was 69.1 (10.5) years, with 57.3% women and 33.5% black, significantly exceeding representation in the single-center cohort (P = .04 and P < .001, respectively). Of 1,231 participants, 286 (23.2%) needed glaucoma surgery. When applying the single-center model to AoU data, accuracy was 0.69 and AUC was only 0.49. Using AoU data to train new models resulted in superior performance: AUCs ranged from 0.80 (logistic regression) to 0.99 (random forests).
CONCLUSIONS: Models trained with national AoU data achieved superior performance compared with using single-center data. Although AoU does not currently include ophthalmic imaging, it offers several strengths over similar big-data sources such as claims data. AoU is a promising new data source for ophthalmic research. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33497675      PMCID: PMC8184631          DOI: 10.1016/j.ajo.2021.01.008

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.488


  39 in total

Review 1.  Machine learning classifiers in glaucoma.

Authors:  Christopher Bowd; Michael H Goldbaum
Journal:  Optom Vis Sci       Date:  2008-06       Impact factor: 1.973

Review 2.  Predictive models to estimate the risk of glaucoma development and progression.

Authors:  Felipe A Medeiros; Robert N Weinreb
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

3.  Efficient learning from big data for cancer risk modeling: A case study with melanoma.

Authors:  Aaron N Richter; Taghi M Khoshgoftaar
Journal:  Comput Biol Med       Date:  2019-04-30       Impact factor: 4.589

4.  Systemic Medication Associations with Presumed Advanced or Uncontrolled Primary Open-Angle Glaucoma.

Authors:  Wei Zheng; Thaddeus P Dryja; Zhongyuan Wei; Dongying Song; Haijun Tian; Kristijan H Kahler; Anthony P Khawaja
Journal:  Ophthalmology       Date:  2018-02-09       Impact factor: 12.079

5.  Time Requirements for Electronic Health Record Use in an Academic Ophthalmology Center.

Authors:  Sarah Read-Brown; Michelle R Hribar; Leah G Reznick; Lorinna H Lombardi; Mansi Parikh; Winston D Chamberlain; Steven T Bailey; Jessica B Wallace; Thomas R Yackel; Michael F Chiang
Journal:  JAMA Ophthalmol       Date:  2017-11-01       Impact factor: 7.389

6.  Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus.

Authors:  Hsien-Chang Lin; Joshua D Stein; Bin Nan; David Childers; Paula Anne Newman-Casey; Debra A Thompson; Julia E Richards
Journal:  JAMA Ophthalmol       Date:  2015-08       Impact factor: 7.389

7.  New Recommendations for the Treatment of Systemic Hypertension and their Potential Implications for Glaucoma Management.

Authors:  Carlos G De Moraes; George A Cioffi; Robert N Weinreb; Jeffrey M Liebmann
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

Review 8.  The pathophysiology and treatment of glaucoma: a review.

Authors:  Robert N Weinreb; Tin Aung; Felipe A Medeiros
Journal:  JAMA       Date:  2014-05-14       Impact factor: 56.272

9.  The Barbados Eye Study. Prevalence of open angle glaucoma.

Authors:  M C Leske; A M Connell; A P Schachat; L Hyman
Journal:  Arch Ophthalmol       Date:  1994-06

10.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

View more
  3 in total

1.  Development and Evaluation of a Rules-based Algorithm for Primary Open-Angle Glaucoma in the VA Million Veteran Program.

Authors:  Cari L Nealon; Christopher W Halladay; Tyler G Kinzy; Piana Simpson; Rachael L Canania; Scott A Anthony; David P Roncone; Lea R Sawicki Rogers; Jenna N Leber; Jacquelyn M Dougherty; Jack M Sullivan; Wen-Chih Wu; Paul B Greenberg; Sudha K Iyengar; Dana C Crawford; Neal S Peachey; Jessica N Cooke Bailey
Journal:  Ophthalmic Epidemiol       Date:  2021-11-25

2.  Identifying developmental stuttering and associated comorbidities in electronic health records and creating a phenome risk classifier.

Authors:  Dillon G Pruett; Douglas M Shaw; Hung-Hsin Chen; Lauren E Petty; Hannah G Polikowsky; Shelly Jo Kraft; Robin M Jones; Jennifer E Below
Journal:  J Fluency Disord       Date:  2021-04-15       Impact factor: 2.538

Review 3.  Applications of natural language processing in ophthalmology: present and future.

Authors:  Jimmy S Chen; Sally L Baxter
Journal:  Front Med (Lausanne)       Date:  2022-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.